Loss of serotonin 2A receptors exceeds loss of serotonergic projections in early Alzheimer's disease: a combined [C]DASB and [F]altanserin-PET study |
| |
Authors: | Lisbeth Marner Vibe G Frokjaer Jan Kalbitzer Szabolcs LehelKarine Madsen William FC Baaré Gitte M Knudsen Steen G Hasselbalch |
| |
Institution: | a Neurobiology Research Unit, The Neuroscience Centre, Copenhagen, Denmark b Center for Integrated Molecular Brain Imaging, Copenhagen, Denmark c PET and Cyclotron Unit, Copenhagen, Denmark d Danish Research Center for Magnetic Resonance, Hvidovre Hospital, Copenhagen, Denmark e The Memory Clinic, University Hospital Rigshospitalet, Copenhagen, Denmark |
| |
Abstract: | In patients with Alzheimer's disease (AD), postmortem and imaging studies have revealed early and prominent reductions in cerebral serotonin 2A (5-HT2A) receptors. To establish if this was due to a selective disease process of the serotonin system, we investigated the cerebral 5-HT2A receptor and the serotonin transporter binding, the latter as a measure of serotonergic projections and neurons. Twelve patients with AD (average Mini Mental State Examination MMSE]: 24) and 11 healthy age-matched subjects underwent positron emission tomography (PET) scanning with 18F]altanserin and 11C]N,N-Dimethyl-2-(2-amino-4-cyanopheylthio)benzylamine (11C]DASB). Overall 18F]altanserin binding was markedly reduced in AD by 28%-39% (p = 0.02), whereas the reductions in 11C]DASB binding were less prominent and mostly insignificant, except for a marked reduction of 33% in mesial temporal cortex (p = .0005). No change in 11C]DASB binding was found in the midbrain. We conclude that the prominent reduction in neocortical 5-HT2A receptor binding in early AD is not caused by a primary loss of serotonergic neurons or their projections. |
| |
Keywords: | Positron emission tomography Brain Serotonin Serotonin transporter Imaging 5-HT Serotonin 2A Dementia Atrophy [18F]altanserin [11C]DASB |
本文献已被 ScienceDirect 等数据库收录! |
|